Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Platz

Showing results (451-460 of 590) with videos related to

Pageof 59
Sort By:
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 1, 2015
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention TrialSarah H Nash, Jeannette M Schenk, Alan R Kristal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2014
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patientsAnnemarie Boleij, Elizabeth M Hechenbleikner, Andrew C Goodwin, et al.
Nature Communications|November 23, 2024
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasmsYun Soo Hong, Sergiu Pasca, Wen Shi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 16, 2024
Alcohol Consumption Does not Modify the Polygenic Risk Score-Based Genetic Risk of Breast Cancer in Postmenopausal Women: Atherosclerosis Risk in Communities StudyMinghui Zhang, Meng Ru, Jingning Zhang, et al.
Journal of the American College of Cardiology|June 30, 2022
Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) StudyRoberta Florido, Natalie R Daya, Chiadi E Ndumele, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
The Prostate|August 23, 2018
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-upMarvin E Langston, Ratna Pakpahan, Remington L Nevin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
Pageof 59

Showing results (451-460 of 590) with videos related to

Sort By:
Pageof 59
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 1, 2015
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention TrialSarah H Nash, Jeannette M Schenk, Alan R Kristal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2014
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patientsAnnemarie Boleij, Elizabeth M Hechenbleikner, Andrew C Goodwin, et al.
Nature Communications|November 23, 2024
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasmsYun Soo Hong, Sergiu Pasca, Wen Shi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 16, 2024
Alcohol Consumption Does not Modify the Polygenic Risk Score-Based Genetic Risk of Breast Cancer in Postmenopausal Women: Atherosclerosis Risk in Communities StudyMinghui Zhang, Meng Ru, Jingning Zhang, et al.
Journal of the American College of Cardiology|June 30, 2022
Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) StudyRoberta Florido, Natalie R Daya, Chiadi E Ndumele, et al.
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
The Prostate|August 23, 2018
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-upMarvin E Langston, Ratna Pakpahan, Remington L Nevin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
Pageof 59